Raymond James & Associates ALDER BIOPHARMACEUTICALS INC Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 14, 2018
SELL
N/A
-11,002 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
N/A
66 Added 0.6%
11,002 $126,000
Q3 2017

Nov 13, 2017
SELL
N/A
-406 Reduced 3.58%
10,936 $134,000
Q2 2017

Aug 14, 2017
BUY
N/A
11,342
11,342 $130,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email